Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Melanoma 4Skin Neoplasms 1Rhabdomyosarcoma 1Osteosarcoma 1Neoplasms 1Lung Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Head and Neck Neoplasms 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 19Nivolumab 16Cyclophosphamide 9Specimen Handling 7Ipilimumab 7atezolizumab 6fludarabine 5Magnetic Resonance Spectroscopy 5durvalumab 3avelumab 3X-Rays 3Biopsy 3ulixertinib 2sargramostim 2poly ICLC 2lenvatinib 2epacadostat 2enzalutamide 2cemiplimab 2cabozantinib 2budigalimab 2aldesleukin 2Trastuzumab 2Sirolimus 2Paclitaxel 2Melphalan 2Interleukin-2 2Immunoglobulin G 2Immune Checkpoint Inhibitors 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × dostarlimab × Dermatologic × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡